Navigation Links
Advanced Specialty Rx

FLINT, Mich., July 30, 2012 /PRNewswire-iReach/ -- Advanced Specialty Rx (ASRx) has opened its long term care pharmacy. ASRx is located inside of the Great Lakes Technology center once home to General Motors Headquarters. Advanced Specialty Rx is focused on servicing Michigan's skilled nursing facilities, long term care facilities, assisted living facilities, rehabilitation centers & other institutional care settings. Caring for the elderly and special needs residents in the long-term care setting is an important job. ASRx strongly believes that providing pharmacy support and services to caregivers is CRITICAL.

"ASRx is opening as a joint venture with Joseph Dourra,Rph, the owner of Advanced Homecare Pharmacy, Rockford, MI. This venture is going to advance the level of experience and expertise to ASRx as a provider to the skilled nursing industry and strengthen the level of service to cover the entire state of Michigan. "He brings to the team over seven years of experience as a pharmacy owner servicing the SNF industry and 5 years of skilled nursing experience working with a national pharmacy provider. This complements our staff's strong experience in servicing skilled nursing and independent living facilities. Aside from his pharmaceutical expertise, he adds a leading edge in technology and computer programming to our company, said Bassam Youssef, R.Ph., CEO of Advanced Specialty Rx.  "Our staff is growing consistently stronger in coordinating pharmacy services within the skilled nursing facilities, holding a combined industry experience of over 55 years." said Bassam Youssef, R.Ph., CEO of Advanced Specialty Rx.

About Advanced Specialty Rx

ASRx's clinical pharmacists and staff members are experts in managing the complex requirements of long term care and providing compassionate care.  Advanced Specialty Rx offers Michigan a statewide pharmacy service. Please visit: or

Media Contact: Kim Hayward Advanced Specialty Rx, 810.232.2700,

News distributed by PR Newswire iReach:

SOURCE Advanced Specialty Rx
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care
2. VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer
3. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
4. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
5. Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients
6. Reduction of Chemotherapy and PET-Guided Radiotherapy in Advanced-Stage Hodgkin Lymphoma: the GHSG HD15 Trial
7. Abbott Presents Results of Clinical Studies Evaluating Its Investigational Treatment for Advanced Parkinsons Disease
8. PeriGen, Inc. Introduces New, Advanced Perinatal System at National Perinatal Nursing Convention
9. Advanced Radiotherapy Techniques Explored at Educational Events in India
10. Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
11. Health Diagnostic Laboratory, Inc. (HDL, Inc.) Brings Advanced Testing to Capitol Hill, Discusses Health Care Cost Savings and Quality Improvement Potential
Post Your Comments:
(Date:12/1/2015)... 01, 2015 ... addition of the "2016 Europe ... E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, ... their offering. --> ... the "2016 Europe Enteric Disease ...
(Date:12/1/2015)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... that the company will present at the LD Micro Main ... Luxe Sunset Boulevard Hotel in Los Angeles, CA. ... will present on Thursday, December 3, at 9:00 am Pacific ... register at least 10 minutes prior to the start of ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken ... for accurate interpretation by the radiologist. The marking utensils are so small, however, ... has found a way to alleviate this problem. , He developed the patent-pending ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates ... a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they ... Society of North America (RSNA) 2015 annual meeting through December 3 in Chicago, ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
Breaking Medicine News(10 mins):